{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:05:40Z","timestamp":1791993940088,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"am","delay-in-days":442,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U24 HG009650"],"award-info":[{"award-number":["U24 HG009650"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymgme.2023.107715","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T21:27:57Z","timestamp":1698355677000},"page":"107715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Variant Classification for Pompe disease; ACMG\/AMP specifications from the ClinGen Lysosomal Diseases Variant Curation Expert Panel"],"prefix":"10.1016","volume":"140","author":[{"given":"Jennifer L.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McGlaughon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dona","family":"Kanavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Goomber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Deml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraka","family":"Donti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce A.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Schachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel G.","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Thaxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa","family":"Udani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Baudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caggana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianna","family":"Kyriakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Pinto e Vairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rehder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ymgme.2023.107715_bb0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.ymgme.2023.107715_bb0010","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/humu.23645","article-title":"ClinGen variant curation expert panel experiences and standardized processes for disease and gene-level specification of the ACMG\/AMP guidelines for sequence variant interpretation","volume":"39","author":"Rivera-Mu\u00f1oz","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2023.107715_bb0030","series-title":"GeneReviews\u00ae [Internet]","article-title":"Pompe disease","author":"Leslie","year":"2007"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41572-023-00456-z","article-title":"Glycogen storage diseases","volume":"9","author":"Hannah","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.ymgme.2023.107715_bb0040","first-page":"3","article-title":"Advances in diagnosis and management of Pompe disease","volume":"24","author":"Davison","year":"2020","journal-title":"J. Mother Child."},{"issue":"7","key":"10.1016\/j.ymgme.2023.107715_bb0045","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.nmd.2014.04.005","article-title":"Atrio-ventricular block requiring pacemaker in patients with late onset Pompe disease","volume":"24","author":"Sacconi","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2023.107715_bb0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpeds.2018.02.007","article-title":"Severe cardiac involvement is rare in patients with late-onset Pompe disease and the common c.-32-13T>G variant: implications for newborn screening","volume":"198","author":"Herbert","year":"2018","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107715_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nmd.2020.10.009","article-title":"Cardiovascular disease in non-classic Pompe disease: a systematic review","volume":"31","author":"van Kooten","year":"2021","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107715_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5603\/PJNNS.a2022.0075","article-title":"Multisystem presentation of late onset Pompe disease: what every consulting neurologist should know","volume":"57","author":"Jastrz\u0119bska","year":"2023","journal-title":"Neurol. Neurochir. Pol."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0065","doi-asserted-by":"crossref","first-page":"107565","DOI":"10.1016\/j.ymgme.2023.107565","article-title":"Pompe disease ascertained through the lantern project, 2018-2021: next-generation sequencing and enzymatic testing to overcome obstacles to diagnosis","volume":"139","author":"Sniderman King","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107715_bb0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2007.09.006","article-title":"Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting","volume":"93","author":"Pompe Disease Diagnostic Working Group","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgme.2023.107715_bb0075","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41436-021-01278-8","article-title":"Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet. Med."},{"issue":"18","key":"10.1016\/j.ymgme.2023.107715_bb0080","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2147\/TCRM.S334232","article-title":"Therapeutic options for the management of pompe disease: current challenges and clinical evidence in therapeutics and clinical risk management","author":"Bolano-Diaz","year":"2022","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2023.107715_bb0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neurol.2022.12.004","article-title":"The new horizons for treatment of late-onset Pompe disease (LOPD)","volume":"179","author":"Gu\u00e9my","year":"2023","journal-title":"Rev. Neurol. (Paris)"},{"issue":"9","key":"10.1016\/j.ymgme.2023.107715_bb0090","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ymthe.2017.05.019","article-title":"Glycogen reduction in Myotubes of late-onset Pompe disease patients using antisense technology","volume":"25","author":"Goina","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2023.107715_bb0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.omtn.2017.03.001","article-title":"Antisense oligonucleotides promote exon inclusion and correct the common c.-32-13T>G GAA splicing variant in pompe disease","volume":"7","author":"van der Wal","year":"2017","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.ymgme.2023.107715_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.omtn.2017.03.002","article-title":"GAA deficiency in pompe disease is alleviated by exon inclusion in iPSC-derived skeletal muscle cells","volume":"7","author":"van der Wal","year":"2017","journal-title":"Mol. Ther. Nucl. Acids"},{"issue":"5","key":"10.1016\/j.ymgme.2023.107715_bb0105","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41436-019-0738-0","article-title":"Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease: a clinical study and review of the literature","volume":"22","author":"Khan","year":"2020","journal-title":"Genet. Med."},{"issue":"21","key":"10.1016\/j.ymgme.2023.107715_bb0110","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.3390\/jcm10214828","article-title":"A systematic review and Meta-analysis of enzyme replacement therapy in late onset Pompe disease","volume":"10","author":"Dornelles","year":"2021","journal-title":"J. Clin. Med."},{"issue":"13","key":"10.1016\/j.ymgme.2023.107715_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.21037\/atm.2019.05.47","article-title":"Newborn screening: Taiwanese experience","volume":"7","author":"Chien","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107715_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ijns9020020","article-title":"Implementation of newborn screening for conditions in the United States first recommended during 2010-2018","volume":"9","author":"Singh","year":"2023","journal-title":"Int. J. Neonatal. Screen."},{"issue":"10","key":"10.1016\/j.ymgme.2023.107715_bb0125","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2017.26","article-title":"Using high-resolution variant frequencies to empower clinical genome interpretation","volume":"19","author":"Whiffin","year":"2017","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-021-01004-8","article-title":"ClinGen variant curation Interface: a variant classification platform for the application of evidence criteria from ACMG\/AMP guidelines","volume":"14","author":"Preston","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.ymgme.2023.107715_bb0140","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ymgme.2023.107715_bb0145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13073-019-0690-2","article-title":"Clinical genome resource sequence variant interpretation working group. Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework","volume":"12","author":"Brnich","year":"2019","journal-title":"Genome Med."},{"issue":"D1","key":"10.1016\/j.ymgme.2023.107715_bb0160","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.ymgme.2023.107715_bb0170","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","article-title":"Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience","volume":"160C","author":"Bali","year":"2012","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107715_bb0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","article-title":"Predicting splicing from primary sequence with deep learning","volume":"176","author":"Jaganathan","year":"2019","journal-title":"Cell."},{"issue":"12","key":"10.1016\/j.ymgme.2023.107715_bb0185","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","article-title":"ClinGen sequence variant interpretation working group. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria","volume":"109","author":"Pejaver","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107715_bb0190","article-title":"Application of the acmg\/amp framework to capture evidence relevant to predicted and observed impact on splicing: recommendations from the ClinGen SVI splicing subgroup","author":"Walker","year":"2023","journal-title":"medRxiv"},{"issue":"11","key":"10.1016\/j.ymgme.2023.107715_bb0195","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/humu.23642","article-title":"ClinGen sequence variant interpretation working group. Updated recommendation for the benign stand-alone ACMG\/AMP criterion","volume":"39","author":"Ghosh","year":"2018","journal-title":"Hum. Mutat."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2023.107715_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in the Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107715_bb0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"issue":"13","key":"10.1016\/j.ymgme.2023.107715_bb0215","doi-asserted-by":"crossref","first-page":"281","DOI":"10.21037\/atm.2019.05.47","article-title":"Newborn screening: Taiwanese experience","volume":"7","author":"Chien","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107715_bb0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ijns6040089","article-title":"Newborn screening for Pompe disease: Pennsylvania experience","volume":"6","author":"Ficicioglu","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0225","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s13023-021-02146-z","article-title":"Current status of newborn screening for Pompe disease in Japan","volume":"16","author":"Sawada","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2023.107715_bb0230","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/humu.23878","article-title":"On behalf of the Pompe registry sites. GAA variants and phenotypes among 1,079 patients with Pompe disease: data from the Pompe registry","volume":"40","author":"Reuser","year":"2019","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107715_bb0235","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41431-020-00752-2","article-title":"Enzymatic diagnosis of Pompe disease: lessons from 28 years of experience","volume":"29","author":"Ni\u00f1o","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107715_bb0240","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1002\/humu.20745","article-title":"Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating","volume":"29","author":"Kroos","year":"2008","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.ymgme.2023.107715_bb0245","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/humu.22108","article-title":"Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants","volume":"33","author":"Kroos","year":"2012","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.c.31318","article-title":"The genotype-phenotype correlation in Pompe disease","volume":"160C","author":"Kroos","year":"2012","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2023.107715_bb0255","article-title":"The molecular basis for Pompe disease revealed by the structure of human acid \u03b1-glucosidase","author":"Deming","year":"2023","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0260","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41467-017-01263-3","article-title":"Structure of human lysosomal acid \u03b1-glucosidase-a guide for the treatment of Pompe disease","volume":"8","author":"Roig-Zamboni","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107715_bb0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/humu.24148","article-title":"Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease-associated variants, common sequence variants, and results from newborn screening","volume":"42","author":"de Faria","year":"2021","journal-title":"Hum. Mutat."},{"issue":"21","key":"10.1016\/j.ymgme.2023.107715_bb0270","doi-asserted-by":"crossref","first-page":"13507","DOI":"10.1016\/S0021-9258(18)92727-4","article-title":"Human lysosomal alpha-glucosidase. Characterization of the catalytic site","volume":"266","author":"Hermans","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107715_bb0280","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.gim.0000217781.66786.9b","article-title":"Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease","volume":"8","author":"Zhang","year":"2006","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107715_bb0285","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2007.09.006","article-title":"Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting","volume":"93","author":"Pompe Disease Diagnostic Working Group","year":"2008","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.21376","article-title":"Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory","volume":"40","author":"Goldstein","year":"2009","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2023.107715_bb0295","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2011.07.014","article-title":"The use of dried blood spot samples in the diagnosis of lysosomal storage disorders--current status and perspectives","volume":"104","author":"Reuser","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2023.107715_bb0300","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/gim.2018.42","article-title":"ClinGen sequence variant interpretation working group. The ACMG\/AMP reputable source criteria for the interpretation of sequence variants","volume":"20","author":"Biesecker","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107715_bb0305","doi-asserted-by":"crossref","first-page":"1001154","DOI":"10.3389\/fgene.2022.1001154","article-title":"Development of a clinically validated in vitro functional assay to assess pathogenicity of novel GAA variants in patients with Pompe disease identified via newborn screening","volume":"13","author":"Goomber","year":"2022","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107715_bb0310","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/gim.2017.218","article-title":"Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s inherited cardiomyopathy expert panel","volume":"20","author":"Kelly","year":"2018","journal-title":"Genet. Med."},{"issue":"8","key":"10.1016\/j.ymgme.2023.107715_bb0315","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1074\/jbc.M404008200","article-title":"Lysosomal acid alpha-glucosidase consists of four different peptides processed from a single chain precursor","volume":"280","author":"Moreland","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107715_bb0320","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.c.31320","article-title":"Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques","volume":"160C","author":"Young","year":"2012","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2023.107715_bb0325","first-page":"100583","article-title":"Urine glucose tetrasaccharide: a good biomarker for glycogenoses type II and III? A study of the French cohort","volume":"23","author":"Piraud","year":"2020","journal-title":"Mol. Genet. Metab. Rep."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:48:49Z","timestamp":1778590129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223003451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":58,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1096719223003451"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107715","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variant Classification for Pompe disease; ACMG\/AMP specifications from the ClinGen Lysosomal Diseases Variant Curation Expert Panel","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107715"}}